People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing drugs, according to a new study.

Inc., an integrated clinical-stage biopharmaceutical company dedicated to developing inhaled medicines, today announced the ...

Aer is utilizing a novel approach to identify and treat mucus plug-high COPD ... and Drug Administration ("FDA”) and European ...

Topline results from the groundbreaking Salford Lung Study are encouraging for GSK's new respiratory drug - but ... study of COPD treatment aimed at creating a clinical trial much closer to ...

But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.

After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...

AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...

AstraZeneca’s respiratory drug Fasenra has failed in chronic obstructive pulmonary disease ... were no new safety signals, and AZ is awaiting the outcome of the TERRANOVA trial, due later ...